MTOR and renal carcinoma: In addition, the mTOR pathway (Motzer et al., 2008) and the VEGF signaling pathway (Turner, 2004; Yildiz et al., 2004) involved in the pathogenesis of renal cancer were also enriched in our current study (data not shown).